![CAPRA-S scores and projection of prostate cancer recurrence post-surgery | THE "NEW" PROSTATE CANCER INFOLINK CAPRA-S scores and projection of prostate cancer recurrence post-surgery | THE "NEW" PROSTATE CANCER INFOLINK](https://talkaboutprostatecancer.files.wordpress.com/2011/06/capra-s-outcome1.png)
CAPRA-S scores and projection of prostate cancer recurrence post-surgery | THE "NEW" PROSTATE CANCER INFOLINK
![Decipher identifies men with otherwise clinically favorable-intermediate risk disease who may not be good candidates for active surveillance | Prostate Cancer and Prostatic Diseases Decipher identifies men with otherwise clinically favorable-intermediate risk disease who may not be good candidates for active surveillance | Prostate Cancer and Prostatic Diseases](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41391-019-0167-9/MediaObjects/41391_2019_167_Fig1_HTML.png)
Decipher identifies men with otherwise clinically favorable-intermediate risk disease who may not be good candidates for active surveillance | Prostate Cancer and Prostatic Diseases
![CAPRA-S scores and projection of prostate cancer recurrence post-surgery | THE "NEW" PROSTATE CANCER INFOLINK CAPRA-S scores and projection of prostate cancer recurrence post-surgery | THE "NEW" PROSTATE CANCER INFOLINK](https://talkaboutprostatecancer.files.wordpress.com/2011/06/capra-s-rev.png)
CAPRA-S scores and projection of prostate cancer recurrence post-surgery | THE "NEW" PROSTATE CANCER INFOLINK
![A calculator for prostate cancer risk 4 years after an initially negative screen: Findings from ERSPC Rotterdam, "Beyond the Abstract," by Xiaoye Zhu, MD and Monique J. Roobol, PhD, MSc A calculator for prostate cancer risk 4 years after an initially negative screen: Findings from ERSPC Rotterdam, "Beyond the Abstract," by Xiaoye Zhu, MD and Monique J. Roobol, PhD, MSc](https://www.urotoday.com/images/stories/Beyond_the_Abstract/bta_zhu_fig1c.jpg)
A calculator for prostate cancer risk 4 years after an initially negative screen: Findings from ERSPC Rotterdam, "Beyond the Abstract," by Xiaoye Zhu, MD and Monique J. Roobol, PhD, MSc
![The Movember Prostate Cancer Landscape Analysis: an assessment of unmet research needs | Nature Reviews Urology The Movember Prostate Cancer Landscape Analysis: an assessment of unmet research needs | Nature Reviews Urology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41585-020-0349-1/MediaObjects/41585_2020_349_Fig1_HTML.png)
The Movember Prostate Cancer Landscape Analysis: an assessment of unmet research needs | Nature Reviews Urology
![Conditional biochemical recurrence-free survival after radical prostatectomy in patients with high-risk prostate cancer - ScienceDirect Conditional biochemical recurrence-free survival after radical prostatectomy in patients with high-risk prostate cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2287888220300507-gr1.jpg)
Conditional biochemical recurrence-free survival after radical prostatectomy in patients with high-risk prostate cancer - ScienceDirect
![PDF) Real-Time Individual Predictions of Prostate Cancer Recurrence Using Joint Models | Yongseok Park - Academia.edu PDF) Real-Time Individual Predictions of Prostate Cancer Recurrence Using Joint Models | Yongseok Park - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/44440769/mini_magick20190214-700-1g426fu.png?1550181616)
PDF) Real-Time Individual Predictions of Prostate Cancer Recurrence Using Joint Models | Yongseok Park - Academia.edu
![Seoul National University prostate cancer calculator (Version 1.1). (A)... | Download Scientific Diagram Seoul National University prostate cancer calculator (Version 1.1). (A)... | Download Scientific Diagram](https://www.researchgate.net/profile/Sang-Lee-107/publication/261444002/figure/fig6/AS:667222758420496@1536089710820/Seoul-National-University-prostate-cancer-calculator-Version-11-A-Main-entry-page_Q640.jpg)
Seoul National University prostate cancer calculator (Version 1.1). (A)... | Download Scientific Diagram
![Not all men with Gleason 8-10 disease are going to do badly after treatment | THE "NEW" PROSTATE CANCER INFOLINK Not all men with Gleason 8-10 disease are going to do badly after treatment | THE "NEW" PROSTATE CANCER INFOLINK](https://talkaboutprostatecancer.files.wordpress.com/2015/09/k2.png)
Not all men with Gleason 8-10 disease are going to do badly after treatment | THE "NEW" PROSTATE CANCER INFOLINK
![The CPC Risk Calculator: A New App to Predict Prostate-specific Antigen Recurrence During Follow-up After Radical Prostatectomy - European Urology Focus The CPC Risk Calculator: A New App to Predict Prostate-specific Antigen Recurrence During Follow-up After Radical Prostatectomy - European Urology Focus](https://www.eu-focus.europeanurology.com/cms/attachment/3cb767c3-7389-4858-8942-56d1d72f27fe/gr1.jpg)